These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6126573)

  • 1. Rate limiting steps in metabolite kinetics: formation of 5-acetylaminosalicylate after administration of 5-aminosalicylate.
    Houston JB; Cassidy MK
    J Pharm Pharmacol; 1982 Aug; 34(8):536-8. PubMed ID: 6126573
    [No Abstract]   [Full Text] [Related]  

  • 2. Aerobic biodegradation of 3-aminobenzoate by gram-negative bacteria involves intermediate formation of 5-aminosalicylate as ring-cleavage substrate.
    Russ R; Müller C; Knackmuss HJ; Stolz A
    FEMS Microbiol Lett; 1994 Sep; 122(1-2):137-43. PubMed ID: 7958765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of enteric bacteria in the anaerobic metabolism of 5-aminosalicylate.
    Tucker MA; Bisesi MS; Smith TJ
    J Biochem Toxicol; 1989; 4(4):267-8. PubMed ID: 2634099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New metabolites of the drug 5-aminosalicylic acid. I: N-beta-D-glucopyranosyl-5-aminosalicylic acid.
    Tjørnelund J; Hansen SH; Cornett C
    Xenobiotica; 1989 Aug; 19(8):891-9. PubMed ID: 2815831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of 5-aminosalicylate to the guinea pig cecum.
    Salata K; Dull BJ; Goldman P
    Biochem Pharmacol; 1987 Jan; 36(2):295-7. PubMed ID: 3814172
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetics of 5-aminosalicylic acid after jejunal instillation in man.
    Haagen Nielsen O; Bondesen S
    Br J Clin Pharmacol; 1983 Dec; 16(6):738-40. PubMed ID: 6661362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capacity-limited gut wall metabolism of 5-aminosalicylic acid, a therapeutically active metabolite of sulfasalazine, in rats.
    Pieniaszek HJ; Bates TR
    J Pharm Sci; 1979 Oct; 68(10):1323-5. PubMed ID: 41931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific measurement of 5-aminosalicylic acid and its acetylated metabolite in human bile.
    Fischer C; Maier K; Klotz U
    Br J Clin Pharmacol; 1983 Feb; 15(2):273-4. PubMed ID: 6849763
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-aminosalicylic acid in serum and urine after administration by enema to patients with colitis.
    Dew MJ; Cardwell M; Kidwai NS; Evans BK; Rhodes J
    J Pharm Pharmacol; 1983 May; 35(5):323-4. PubMed ID: 6134804
    [No Abstract]   [Full Text] [Related]  

  • 10. Bacterial metabolism of 5-aminosalicylic acid. Initial ring cleavage.
    Stolz A; Nörtemann B; Knackmuss HJ
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):675-80. PubMed ID: 1554350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible mechanism of action of sulfasalazine and 5-aminosalicylic acid in inflammatory bowel diseases: interaction with oxygen free radicals.
    Del Soldato P; Campieri M; Brignola C; Bazzocchi G; Gionchetti P; Lanfranchi GA; Tamba M
    Gastroenterology; 1985 Nov; 89(5):1215-6. PubMed ID: 2864302
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of the intestinal flora in the acetylation of sulfasalazine metabolites.
    Dull BJ; Salata K; Goldman P
    Biochem Pharmacol; 1987 Nov; 36(21):3772-4. PubMed ID: 2890356
    [No Abstract]   [Full Text] [Related]  

  • 13. [Salazosulfapyridine or 5-aminosalicylic acid].
    Terpstra JJ
    Ned Tijdschr Geneeskd; 1987 Aug; 131(32):1409-10. PubMed ID: 2889151
    [No Abstract]   [Full Text] [Related]  

  • 14. Sulfasalazine and 5-ASA compounds.
    Allgayer H
    Gastroenterol Clin North Am; 1992 Sep; 21(3):643-58. PubMed ID: 1355468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans.
    Rasmussen SN; Bondesen S; Hvidberg EF; Hansen SH; Binder V; Halskov S; Flachs H
    Gastroenterology; 1982 Nov; 83(5):1062-70. PubMed ID: 7117789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay of 5-aminosalicylate and its acetylated metabolite in biological fluids by high-performance liquid chromatography on dynamically modified silica.
    Hansen SH
    J Chromatogr; 1981 Dec; 226(2):504-9. PubMed ID: 6274891
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of the gastrointestinal absorption of p-aminosalicylate (PAS) in rats and humans by diphenhydramine.
    Lavigne JG; Marchand C
    Clin Pharmacol Ther; 1973; 14(3):404-12. PubMed ID: 4698569
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers.
    Sandborn WJ; Hanauer SB; Buch A
    Aliment Pharmacol Ther; 2004 May; 19(10):1089-98. PubMed ID: 15142198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negligible excretion of 5-aminosalicylic acid in breast milk.
    Klotz U; Harings-Kaim A
    Lancet; 1993 Sep; 342(8871):618-9. PubMed ID: 8102746
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxidation of 5-aminosalicylic acid by hypochlorous acid to a reactive iminoquinone. Possible role in the treatment of inflammatory bowel diseases.
    Liu ZC; McClelland RA; Uetrecht JP
    Drug Metab Dispos; 1995 Feb; 23(2):246-50. PubMed ID: 7736919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.